These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 300412)

  • 1. Evidence that human alpha-lymphotoxin is not an RNase.
    Moy J; Rosenau W
    J Immunol; 1977 Apr; 118(4):1507-8. PubMed ID: 300412
    [No Abstract]   [Full Text] [Related]  

  • 2. The LT system in experimental animals. I. Rapid release of high levels of lymphotoxin (LT) activity from murine lymphocytes during the interaction with lectin-treated allogeneic or xenogeneic target cells in vitro.
    Hiserodt JC; Tiangco GJ; Granger GA
    J Immunol; 1979 Jul; 123(1):311-6. PubMed ID: 312876
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of lymphotoxin in target cell destruction induced by mitogen-activated human lymphocytes in vitro. II. The correlation of temperature and trypsin-sensitive phases of lymphotoxin-induced and lymphocyte-mediated cytotoxicity.
    Kramer SL; Granger GA
    J Immunol; 1976 Feb; 116(2):562-7. PubMed ID: 1082459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphotoxin. A review and analysis.
    Rosenau W; Tsoukas CD
    Am J Pathol; 1976 Sep; 84(3):580-96. PubMed ID: 786035
    [No Abstract]   [Full Text] [Related]  

  • 5. The LT system in experimental animals. III. Physicochemical characteristics and relationships of lymphotoxin (LT) molecules released in vitro by activated lymphoid cells from several animal species.
    Ross MW; Tiangco GJ; Horn P; Hiserodt JC; Granger GA
    J Immunol; 1979 Jul; 123(1):325-31. PubMed ID: 312878
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory factors produced by lymphocytes. I. The occurrence of multiple alpha-lymphotoxins associated with ribonuclease activity.
    Lee SC; Lucas ZJ
    J Immunol; 1976 Jul; 117(1):283-91. PubMed ID: 1084366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LT system in experimental animals. II. Physical and immunologic characteristics of molecules with LT activity rapidly released by murine lymphoid cells activated on lectin-coated allogeneic monolayers in vitro.
    Hiserodt JC; Tiangco GJ; Granger GA
    J Immunol; 1979 Jul; 123(1):317-24. PubMed ID: 312877
    [No Abstract]   [Full Text] [Related]  

  • 8. Human alpha lymphotoxin (LT): studies examining the mechanism(s) of LT-induced inflammation and tumor destruction in vivo.
    Jeffes EW; Averbook BJ; Ulich TR; Granger GA
    Lymphokine Res; 1987; 6(2):141-9. PubMed ID: 3495706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytotoxic effect of soluble factor formed by lymphocytes of palatine tonsils in transplantable cell culture in vitro].
    Kondrattsova TP; Vershigora AIu; Krivokhats'ka LD
    Mikrobiol Zh; 1975; 37(5):624-8. PubMed ID: 1082972
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro lymphocyte cytotoxicity. I. Evidence of multiple cytotoxic molecules secreted by mitogen activated human lymphoid cells in vitro.
    Hiserodt JC; Prieur AM; Granger GA
    Cell Immunol; 1976 Jun; 24(2):277-88. PubMed ID: 1084788
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of lymphotoxin in target cell destruction by mitogen-activated human lymphocytes. I. The correlation of target cell sensitivity to lymphotoxin and the intact lymphocyte.
    Kramer SL; Granger GA
    Cell Immunol; 1975 Jan; 15(1):57-68. PubMed ID: 1078544
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro lymphocyte cytotoxicity. II. Unstable lymphotoxins (beta-LT) secreted and inactivated by mitogen-stimulated human lymphocytes.
    Hiserodt JC; Granger GA
    Cell Immunol; 1976 Oct; 26(2):211-6. PubMed ID: 1086143
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic activity of lymphocytes. VIII. Lymphotoxin activity in cell-free extracts of activated lymphocytes.
    Lee SC; Lucas ZJ
    Cell Immunol; 1979 Nov; 48(1):166-81. PubMed ID: 315829
    [No Abstract]   [Full Text] [Related]  

  • 14. Dissociation of lymphotoxin production and lymphocyte blast cell transformation in acute lymphoblastic leukemia after cessation of long-term immunosuppressive therapy.
    Eife R; Trowitzsch L; Lampert F
    Klin Padiatr; 1974 Nov; 186(6):483-8. PubMed ID: 4548474
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte effector molecules and cell-mediated immune reactions.
    Granger GA; Daynes RA; Runge PE; Prieur AM; Jeffes EW
    Contemp Top Mol Immunol; 1975; 4():205-41. PubMed ID: 1104257
    [No Abstract]   [Full Text] [Related]  

  • 16. The human LT system. VII. Release of soluble forms and delivery to target L-929 cells by lectin-preactivated human lymphocytes in the absence of protein synthesis and secretory processes.
    Hiserodt JC; Ford SC; Harris PC; Granger GA
    Cell Immunol; 1979 Sep; 47(1):32-45. PubMed ID: 315825
    [No Abstract]   [Full Text] [Related]  

  • 17. Spontaneous cytotoxicity (SCMC) of normal human lymphocytes against a human melanoma cell line: a phenomenon due to a lymphotoxin-like mediator.
    Peter HH; Eife RF; Kalden JR
    J Immunol; 1976 Feb; 116(2):342-8. PubMed ID: 1082453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison and yield of antigen- or mitogen-induced human lymphotoxins.
    Boulos GN; Rosenau W; Goldberg ML
    J Immunol; 1974 Apr; 112(4):1347-53. PubMed ID: 4273626
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytotoxic activity of lymphocytes. VI. Heterogeneity of cytotoxins in supernatants of mitogen-activated lymphocytes.
    Walker SM; Lee SC; Lucas ZJ
    J Immunol; 1976 Mar; 116(3):807-15. PubMed ID: 1082895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human lymphocyte-mediated mitogen-induced cytotoxicity of murine L-929 cells by heterologous anti-human lymphotoxin antisera in vitro.
    Hiserodt JC; Granger GA
    J Immunol; 1977 Aug; 119(2):374-80. PubMed ID: 301888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.